Teva Pharmaceutical Industries LimitedTEVANYSE
Loading
Revenue PerformanceStable
Percentile Rank43
3Y CAGR+5.0%
5Y CAGR+0.7%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+5.0%/yr
vs -5.7%/yr prior
5Y CAGR
+0.7%/yr
Recent acceleration
Acceleration
+10.6pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $17.26B | +4.3% |
| 2024 | $16.54B | +4.4% |
| 2023 | $15.85B | +6.2% |
| 2022 | $14.93B | -6.0% |
| 2021 | $15.88B | -4.7% |
| 2020 | $16.66B | -1.4% |
| 2019 | $16.89B | -10.4% |
| 2018 | $18.85B | -15.8% |
| 2017 | $22.39B | +2.2% |
| 2016 | $21.90B | - |